MOLN Stock Analysis: Buy, Sell, or Hold?
MOLN - Molecular Partners AG American Depositary Shares
$3.80
-0.04 (-1.04%)
▼
5d:
-7.32%
30d:
-9.09%
90d:
-19.15%
HOLD
MODERATE Confidence
Analysis Updated: May 18, 2026 12:00 AM ET
Earnings: Jun 03, 2026
14d
Get Alerted When MOLN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MOLN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: MOLN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$8.09
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$5.02
24.4% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MOLN is currently trading at $3.80, which is considered oversold relative to its 30-day fair value range of $4.05 to $4.39. From a valuation perspective, the stock is trading at a discount (Forward PE: 16.4) compared to its historical average (47.4). Remarkably, the market is currently pricing in an annual earnings decline of 29.7% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, MOLN is showing sideways momentum. The price is currently testing key support at $3.71. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MOLN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $11.10 (+192.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MOLN is showing sideways momentum. The price is currently testing key support at $3.71. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MOLN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $11.10 (+192.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.05 -
$4.39
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 192.2% below Wall St target ($11.10)
- CAUTION: 5-day price weakness (-7.3%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$4.05 -
$4.39
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.71
Resistance Level
$4.41
Current Trend
Sideways
Technical data as of
May 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.45
Wall Street Target
$11.10
(+192.2%)
Revenue Growth (YoY)
-100.0%
Valuation Discount vs History
-29.7% cheaper
PE vs Historical
16.5 vs 47.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-29.7%
(market-implied from PE analysis)
1-Year Target
$3.42
(-10%)
2-Year Target
$3.08
(-19%)
3-Year Target
$2.77
(-27%)
3-Yr Target (if PE normalizes)
(PE: 16→47)
$7.98
(+110%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 16.5 to 47.4
Stabilization Target:
$10.95
(+188.1%)
PE Expansion Potential:
+188.1%
Share & Embed Analysis
Last updated: May 18, 2026 9:08 PM ET
Data refreshes hourly during market hours. Next update: 10:08 PM
Data refreshes hourly during market hours. Next update: 10:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MOLN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 63 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 56 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$875 | 45 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$242 | 64 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 53 HOLD |
